Litcius/Paper detail

MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism

Lida Du, Cheng Fang, Yueqing Wang, Ziying Feng, Ogunleye Femi Abiola, Zhaolin Gao, Juyang Huang, Yinzhong Ma

2025Acta Pharmacologica Sinica18 citationsDOI

Topics & Concepts

AstrogliosisNeuroprotectionMicrogliaNeuroinflammationPharmacologyMatrix metalloproteinaseBlood–brain barrierAstrocyteStroke (engine)PterostilbeneMedicineInflammationImmunologyInternal medicineCentral nervous systemMechanical engineeringEngineeringResveratrolNeuroinflammation and Neurodegeneration MechanismsSphingolipid Metabolism and SignalingPeroxisome Proliferator-Activated Receptors
MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism | Litcius